MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)
Condition(s):Paranoid SchizophreniaLast Updated:August 3, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Paranoid SchizophreniaLast Updated:August 3, 2015Completed
Condition(s):Paranoid Schizophrenia; SchizophreniaLast Updated:August 21, 2015Completed
Condition(s):Schizophrenia, Paranoid; Schizophrenia, Disorganized; Schizophrenia, UndifferentiatedLast Updated:February 9, 2022Completed
Condition(s):Schizophrenia, Paranoid; Schizophrenia, Disorganized; Schizophrenia, UndifferentiatedLast Updated:February 9, 2022Completed
Condition(s):Schizophrenia, Catatonic; Schizophrenia, Disorganized; Schizophrenia, Paranoid; Schizophrenia; Psychotic DisordersLast Updated:July 7, 2010Unknown status
Condition(s):Schizophrenia, Schizotypal and Delusional DisordersLast Updated:April 8, 2022Completed
Condition(s):Late Onset Schizophrenia; Delusional Disorder (Late Onset)Last Updated:March 28, 2024Recruiting
Condition(s):Schizophrenia; Delusional Disorders (ICD-10)Last Updated:March 28, 2008Unknown status
Condition(s):Schizophrenia; Schizoaffective Disorder; Delusional Disorder; Schizophreniform DisordersLast Updated:May 23, 2022Completed
Condition(s):Schizophrenia; Schizoaffective Disorder; Delusional DisorderLast Updated:March 8, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.